期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

HIV疫苗研究进展及面临的困难 被引量：4

HIV vaccine: progress and challenge
原文传递
导出
摘要 HIV疫苗的发展艰辛而缓慢.目前,即使是被认为最有效的RV144疫苗,也只能将感染率降低31％[1].本文就HIV疫苗的研究进展和疫苗研制所面临的困难进行综述. 1 HIV疫苗研究现状 HIV疫苗可分为传统疫苗和新型疫苗两大类.传统疫苗包括减毒活疫苗和灭活病毒疫苗.新型疫苗包括DNA疫苗、病毒样颗粒(VLP)疫苗、载体疫苗和蛋白亚单位疫苗等.
作者 付春云 戴盛明
机构地区 广西医科大学第四附属医院检验科
出处 《中华临床感染病杂志》 CAS 2013年第2期125-128,共4页 Chinese Journal of Clinical Infectious Diseases
关键词 HIV 疫苗 研究
分类号 R392 [医药卫生—免疫学]
  • 相关文献

参考文献32

  • 1Robb M. HIV vaccine development:a new beginning[J].Expert Rey Vaccines,2011.925-927.
  • 2Gurunathan S,Klinman DM,Seder RA. DNA vaccines:immunology,application,and optimization[J].Annual Review of Immunology,2000.927-974.
  • 3Mahdavi M,Ebtekar M,Khorram Khorshid HR. ELISPOT analysis of a new CTL based DNA vaccine for HIV-1 using GMCSF in DNA prime/peptide boost strategy:GM-CSF induced longlived memory responses[J].Immunology letters,2011.14-20.
  • 4Goldoni AL,Maciel M Jr,Rigato PO. Mucosal and systemic anti-GAG immunity induced by neonatal immunization with HIV LAMP/gag DNA vaccine in mice[J].Immunobiology,2011.505-512.
  • 5Catanzaro AT,Roederer M,Koup RA. Phase I clinical evaluation of a six-plasmid multiclade HIV-1 DNA candidate vaccine[J].Vaccine,2007.4085-4092.
  • 6Vuola JM,Keating S,Webster DP. Differential immunogenicity of various heterologous prime-boost vaccine regimens using DNA and viral vectors in healthy volunteers[J].Journal of Immunology,2005.449455.
  • 7Chhatbar C,Mishra R,Kumar A. HIV vaccine:hopes and hurdles[J].Drug Discovery Today,2011.948-956.
  • 8McBurney SP,Ross TM. Hunan immunodeficiency virus-like particles with consensus envelopes elicited broader cell-mediated peripheral and mucosal immune responses than polyvalent and monovalent Env vaccines[J].Vaccine,2009.4337-4349.
  • 9Hammonds J,Chen X,Zhang X. Advances in methods for the production,purification,and characterization of HIV-1 GagEnv pseudovirion vaccines[J].Vaccine,2007.8036-8048.
  • 10Somogyi E,Xu JQ,Gudics A. A plasmid DNA immunogen expressing fifteen protein antigens and complex virus-like particles (VLP +) mimicking naturally occurring HIV[J].Vaccine,2011.744-753.

同被引文献44

  • 1中华医学会感染病学分会艾滋病学组.艾滋病诊疗指南(2011版)[J].中华临床感染病杂志,2011,4(6). 被引量：380
  • 2刘颖,段丹丽,彭虹,唐海丽,刘沙,张宁,王宁,刘建源,邵一鸣.HIV复制型痘苗病毒载体疫苗免疫原性分析[J].中华实验和临床病毒学杂志,2004,18(3):281-283. 被引量：9
  • 3重症患者侵袭性真菌感染诊断与治疗指南(2007)[J].中华内科杂志,2007,46(11):960-966. 被引量：434
  • 4De Francesco R, Caffi A. Advances in the development of newtherapeutic agents targeting the NS3-4A serine protease or the NSSB RNA-dependent RNA polymerase of the hepatitis C virus [J]. Adv Drug Deliv Rev, 2007, 59:1242-1262.
  • 5Hui CY, Xie XB, Cao H, et aL The development of novel tat v NS3-4A protease inhibitors[J]. Anti infective agents, 2013, 11: 125-135.
  • 6Imhof I, Simmonds F. Development of an intergenotypie hepatitis C virus (HCV) cell culture method to assess antiviral susceptibilities and resistance development of HCV NS3 protease genes from HCV genotypes 1 to 6 [ J ]. J irol, 2010, 84:4597- 4610.
  • 7Jones DM, McLauchlan J. Hepatitis C virus : assembly and release of virus particles[ J]. J Biol Chem, 2010, 285:22733-22739.
  • 8Raney KD, Sharma SD, Moustafa IM, et al. Hepatitis C virus non-structural protein 3 ( HCV NS3 ) : a multifunctional antiviral target[J]. J Biol Chem, 2010, 285:22725-22731.
  • 9Gale M Jr, Foy EM. Evasion of intracellular host defence by hepatitis C virus[ J]. Nature, 2005, 436:939-945.
  • 10Lemon SM. Induction and evasion of innate antiviral responses by hepatitis C virus[ J]. J Biol Chem, 2010, 285:22741-22747.

引证文献4

二级引证文献25

中华临床感染病杂志
2013年 第2期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部